PLASMIDS, METHODS FOR CONTRUCTION OF THE SAME, MICROORGANISMS CARRYING THE PLASMIDS AND METHODS FOR CULTIVATION OF THE MICROORGANISMS

Abstract: Novel plasmids pEAP2 and PCX311, which were con­ structed from Bacillus sp. chromosomal DNA carrying the gene for extracellular production of such high-molecular sub­ stances as penicillinase and xylanase, and a vector plasmid pMB9 or pBR322. A novel microorganism, Escherichia coli HB101 carrying the plasmid pEAP2 [Escherichia coli HB101 (pEAP2)] and being capable of extracellular production of penicillinase. A novel microorganism, Escherichia coli HB101 carrying the plasmid pCX311 [Excherichia coli HB101 (pCX311)] and being capable of extracellular production of xylanase. Methods for cultivation of the microorganisms characterized by culturing them in the medium containing NaCl (or KCl), or NaCl (or KCl) and bran, or NaCl (or KCl) and xylan for 12-48 hours.

Description: This invention relates to novel plasmids, which are capable of inducing the extra cellular secretion of penicillinase in Escherichia coli to methods for the construction of said plasmids novel microorganisms carrying said plasmids, and for methods for the extracellular production of penicillinase comprising the cultivation of said microorganisms. Plasmids are non-chromosomal elements of cyclic DNA found in a microorganism cell. Plasmids are currently being used as a means for recombination of microorganism genes and are becoming more and more important in the field of fermentation industry. Studies have recently been done on plasmids carrying foreign DNA having genetic information of metabolic products of specific demand for growth of microorganism, as shown in production of amino acids or peptides. Some plasmids have been introduced into host microorganisms to obtain transformants. Methods have been proposed for producing relatively low molecular compounds such as amino acids and peptides by cultivating the transformants. However, the degree of propagation of plasmids carrying genes for production of high-molecular substances depends on the nature of host microorganisms and those plasmids have not effectively been expressed. Furthermore, no effective methods for cultivation of such transformants have been established. It has not been possible to selectively obtain a certain extracellular high-molecular product by cultivating a microorganism transformed with a plasmid carrying foreign DNA fragment having genetic information of extracellular production of high-molecular substances which are metabolic products of other microorganisms. Such extracellular production has not successfully been done even when a transformant of Escherichia species, which is usually used as a host microorganism, is used. US-A-4,411,994 of W.Gilbert et al discloses a process for producing specific proteins in bacteria and having them excreted from the bacterial cell. This process comprises inserting the DNA coding for the desired non-bacterial protein or part of a protein by recombinant techniques into a plasmid or phage gene which codes for either a periplasmic or an extracellular protein, hereinafter called a "carrier protein", then transforming a bacterial host with the recombinant DNA and culturing the transformed host to excrete the protein. The process of this patent provides a means for producing a selected protein by employing a gene for a carrier protein which has a leader sequence of hydrophobic amino acids at its amino terminus. The cell wall of Escherichia coli which has often been used for production of useful physiologically active substances, consists of three kinds of membrane: inner membrane, peptido glycan and outer membrane. The space between the inner and outer membrane is called the periplasmic space. The process of US-A-4,411,994 has succeeded in the excretion of the products into the periplasmic space but not into the culture medium through the outer membrane or outside the bacterial host cell. In the present invention, by inserting the DNA having genetic information of extracellular production of high-molecular substances into the plasmid to obtain a hybrid plasmid and culturing the host transformed with the hybrid plasmid, it is possible to excrete useful physiologically active substances through the outer membrane and recover them directly from the culture medium. Thus, the present invention makes mass production of useful physiologically active substances possible, which has never been possible by the prior art processes. Therefore, the technical problem underlying the present invention is to provide plasmids which are capable of inducing the extracellular secretion of penicillinase in E. Coli, methods for the construction of said plasmids, novel microorganisms carrying said plasmids and methods for the extra cellular production of penicillinase comprising the cultivation of said microorganisms. The novel plasmids are constucted from a vector plasmid and a DNA fragment containing the genetic information for the extracellular production of penicillinase. These DNA fragments are obtained from microorganisms of the genus Bacillus ."Extracellular production" " means that the penicillinase produced is secreted by the cells into the culture medium. These plasmids can be prepared by a process which comprises preparing, with a restriction enzyme, a chromosomal DNA fragment coding for extracellular production of penicillinase, digesting a plasmid vector DNA with a restriction enzyme which does not interfere with the genetic information carried on the chromosomal DNA fragment, treating the chromosonal DNA fragment and the digested vector plasmid with DNA ligase to form a recombinant plasmid and isolating the recombinant plasmid. Novel microorganisms according to the present invention are those which belong to the genus Escherichia which contain the recombinant plasmid and which have the capability of extracellular production of penicillinase. The present invention also provides a method for the extracellular production of penicillinase by bacteria comprises inoculating said microorganism into a culture medium containing an inorganic salt necessary for the microorganism to grow, or into a culture medium containing a selected carbon source together with the inorganic salt, keeping on culturing the microorganism after the concentration of the microorganism cells reached the maximum and until the production and accumulation of the high-molecular substances in the media reach the maximum. The figures show Fig.1a shows bacterial growth and penicillinase production by Escherichia coli HB101(pEAP2) of the present invention. Fig.1b shows percentages of extracellular, intracellular, and periplasmic cellular penicillinase production by Escherichia coli HB101(pEAP2). Fig.2 shows bacterial growth and penicillinase production by Bacillus sp. No. 170. Fig.3a shows bacterial growth and penicillinase production by Escherichia coli HB101(pBR322). Fig.3b shows percentages of extracellular, intracellular, and periplasmic cellular penicillinase production by Escherichia coli HB101(pBR322). Fig.4 shows the restriction enzyme cleavage map for the plasmid pEAP2. The term "high molecular substances" used in the specification and the claims of this application means useful physiologically active compounds including bacterial metabolic products such as enzyme proteins, antibiotics and the like, and biologically active proteins of mammalian origin. The present invention will now be explained in detail. (a) The Plasmids and their Construction The novel plasmids of the present invention are constructed by inserting a foreign DNA into a plasmid (extrachromosomal DNA or vector DNA), such as Col E₁, found in Escherichia cells. The vector DNA which can be used in the present invention may have been isolated from natural sources. The DNA fragments unnecessary for self-reproduction may have been deleted. Specific examples for vectors which may be used are the plasmids ColE₁, pMB9, pBR322, pSC101, R6K and lambda phage. Foreign DNA fragments or exogenates which can be inserted into the vector DNA are the genes carrying the genetic information for the extracellular production or secretion of penicillinase. Exogenates or DNA fragments which can be used in the present invention include the genes carrying the genetic information for the extracellular production or secretion of penicillinase. They are obtained from a microorganism which belongs to the genus Bacillus. An example of a microorganism containing DNA which carries the genetic information for the extracellular production of penicillinase and which can be used in the present invention is Bacillus sp. No. 170 (Horikoshi K. et al (1976) Agric. Biol. Chem., 40 1363-1367). For the purpose of the insertion of foreign DNA into a vector DNA, any conventional method can be used in the present invention. For instance, chromosomal DNA is digested with a suitable restriction enzyme or endonuclease to obtain a foreign DNA fragment or an exogenate which is then mixed with a vector DNA which has been treated with the same restriction enzyme, and the mixture is ligated by a suitable ligase. Thus, as described before, the novel plasmids of the present invention can be obtained by preparing, with a restriction enzyme, a DNA fragment coding for the extracellular production of penicillinase, digesting a plasmid vector DNA with a restriction enzyme which does not interfere with genetic information carried on the DNA fragment, treating the DNA fragment and the digested vector plasmid with DNA ligase to construct a recombinant plasmid and isolating the recombinant plasmid by a conventional manner [see Bolivar et. al., Gene, 2, 95 (1977)]. The novel plasmid pEAP2 can be constructed from a fragment of Bacillus sp. No . 170 chromosomal DNA and plasmid pMB9. The restriction enzyme map of plasmid pEAP2 is shown in Fig. 4. As seen from Fig. 4, plasmid pEAP2 is constructed from plasmid PMB9 into which the fragment of Bacillus sp. No. 170 chromosomal DNA coding for extracellular penicillinase production is inserted at the Hind III restriction site of plasmid pMB9. Thus, plasmid pEAP2 is a cyclic DNA molecule of about 7700 nucleotide base pairs (7.7 kb), consisting of pMB9 DNA and a fragment of Bacillus sp. No. 170 chromosomal DNA of about 2000 nucletide base pairs (2 kb). (b) Preparation of Microorganisms The recombinant plasmids constructed from the chromosomal DNA fragments and the vector DNA plasmids are introduced into a host microorganism of the genus Escherichia by a conventional transformation technique. Cultivation is kept on until a stabilized genotype is established in order to obtain a transformant carrying both genotypes on the selected chromosomal DNA and on the vector DNA. For this purpose, a conventional, so called shotgun method can be used. A typical host microorganism which can be used in the present invention is Escherichia coli HB101 which is a hybrid strain of Escherichia coli K-12 and Escherichia coli B. The transformant, Escherichia coli HB101 (pEAP2) which is prepared by introducing plasmid pEAP2 into Escherichia coli HB 101 has the same microbiological properties as the host, Escherichia coli HB101, except penicillin resistance [Molecular Cloning,A Laboratory Manual, p.504 (1982), Genotype: F - , hsdS20 (r - B, m B ) , recA13, ara-l4, proA2, lacYl, galK2, rpsL20(5m γ ), xyl-5, mt1-1, supE44λ]. E. coli HB101 (pEAP2) is further characterized by the property of plasmid pEAP2, that is, the capability of extracellular production of penicillinase. The extracellular production of penicillinase by Escherichia coli HB101 (pEAP2), as shown in the Examples, reaches more than 80% of total production including the intracellular production and remains after long cultivation. By contrast, more than 80% of the total penicillinase production of the known strain Escherichia coli HB101 (pBR322) is intracellular and the extracellular penicillinase production of the known strain, Bacillus sp. No. 170 can not be kept for a long period of time. The present invention which provides Escherichia coli HB 101 (pEAP2) having the capability of extracellular production of enzyme proteins such as penicillinase is not only novel but also inventive. Escherichia coli HB101 (pEAP2) can produce and secrete into the medium in addition to large amounts of penicillinase, large amounts of other enzyme proteins which can also be collected. More specifically, it has been discovered that Escherichia coli HB101 (pEAP2) produces and secretes into the medium from the cells large amounts of alkaline phosphatase,β-galactosidase and about ten kinds of proteins which have been observed only within the cells and never outside the cells. Such extracellular production by Escherichia coli HB101 (pEAP2) demonstrates that the DNA of about 2000 nucleotide base pairs carried on plasmid pEAP2 provides the host with the capability of extracellular production of the metabolic products. (c) Cultivation of the microorganisms For culturing the transformants prepared in step (b), any culture media can be used which are suitable for the production of specific substances for which specific genetic information codes and which are suitable for growth of the microorganisms of the genus Escherichia. in the process of the present invention. It is necessary to culture the microorganism in a culture medium containing an inorganic salt necessary for the microorganism to grow, or a selected carbon source together with the inorganic salt, and to keep on culturing the microorganism, after the concentration of the microorganism cells reached the maximum, and until the production and accumulation of the high-molecular substances in the media reach the maximum. Examples of the inorganic salt which can be used in the present invention include sodium and potassium salts such as sodium chloride, sodium sulfate, potassium chloride and the like, among which sodium chloride is preferred. The media containing the inorganic salt or the selected carbon source together with the inorganic salt can contain such carbon sources as glucose, sucrose, lactose, maltose, glycerol, bran, xylan and the like, such nitrogen sources as ammonia water, ammonium salts and the like, inorganic ions and optionally such nutrients as amino acids, vitamins and the like. The culture media which can be used in the present invention are those which use, as a basic medium, LB-broth (containing tryptone, yeast extract and NaCl), BPB-broth (Difco Laboratories; containing polypeptone, yeast extract and K₂HPO₄) , nutrient broth (Difco 0001), tryptone-NaCl broth or the like. Since more than 80% of total products remain in the intracellular fraction in a medium containing no inorganic salt, it is necessary to use a medium containing an inorganic salt so that most products are secreted into the culture medium of the cells. The amount of inorganic salt used is in the range of 0.5 - 3.0% by weight on the basis of the culture medium. In the culture of Escherichia coli HB101 (pEAP2), excellent results are obtained by the use of LB-broth to which glucose and further glycerol have been added as carbon sources, preferably in an amount of 0.1 and 0.2% by weight on the basis of the culture medium, respectively. Although culture conditions such as pH, temperature, oxygen supply or the like can be changed for the optimum growth of the microorganism of the genus Escherichia, it is necessary, in the present invention to keep on culturing the microorganism after the concentration of the microorganism cells reached the maximum, that is to say, after the late logarithmic phase and until the production and accumulation of the high-molecular substances in the medium reach the maximum. After the inoculation of the microorganism of the genus Escherichia into the medium the cell concentration reaches the maximum after 5 to 20 hours and the production and accumulation of the high-molecular substances reach the maximum after 12 to 48 hours. Although the pH of the culture medium is not critical, it is preferably in the range of pH5 - pH8, most preferably pH7. Thus, without further addition of inorganic salt necessary for the microorganism to grow, carbon sources and the like during cultivation, the microorganism produces large amounts of extracellular high-molecular substances which can conveniently be collected. According to the culture method of the present invention such high-molecular fermentation products as antibiotics, polysaccharides can be produced in a significant amount in addition to enzyme proteins. This method can be applied to the cultivation of any microorganisms transformed with a plasmid carrying a foreign DNA coding for biologically active high-molecular substances such as hormone peptides (e.g. insulin) or interferon and the DNA coding for extracellular production or secretion of biologically active high-molecular substances, which leads to mass production of the high-molecular substances such as insulin, interferon and the like. As explaind above, the present invention contributes to the industrial production of useful high-molecular substances. Examples of microorganisms which may be used in this invention include (i) Bacillus sp. No. 170, and Escherichia coli HB101 (pEAP2) which were deposited with the Fermentation Research Institute, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, Japan, International Depository Authority (hereinafter referred to as "FERM") under the accession numbers, FERM BP-467 and FERM BP-468, respectively. They are on deposit with FERM in an unrestricted deposit permitting unrestricted access to the culture. The depository and accession numbers of the above mentioned microorganisms are shown below: The applicant will maintain the deposition of FERM BP-467 and FERM BP-468 in unrestricted form until the end of the duration this patent, and thus said microorganism strains will be available to any third party at any time until the end of the duration of the present patent. Methods for the construction of the plasmids of the present invention, methods for the preparation of the transformant Escherichia coli HB101 (pEAP2), and the extracellular production of penicillinase by this transformant will be explained hereinafter in the examples. Example 1 (1) Preparation of a chromosomal DNA having genetic information for the production of penicillinase. Alkalophilic Bacillus sp. No. 170 (FERM BP-467) having the capability of extracellular production of penicillinase was cultured at 30°C with shaking for 19 hours in the broth (containing 2.0g of glycerol, 5.0g of yeast extract, 5.0g of polypeptone, 10g of K₂HPO₄ , 0.2g of MgSO₄·7H₂O, 10g of NaHCO₃ in one liter of deionized water; pH9.0). The cells in the latter logarithmic phase were collected. The chromosomal DNA was extracted by the phenol extraction method and purified to obtain 5mg of the chromosomal DNA. (2) Insertion of chromosomal DNA fragment into vector DNA. The chromosomal DNA (10µg) obtained in step (1) was digested with the restriction enzyme Hind III at 37°C for 5, 10, 20, 30 and 60 minutes to obtain DNA fragments. Plasmid pMB9 [Bethesda Research Laboratories, U.S.A., tetracyclin resistant (Tet r )] used as the vector was cut with Hind III, heated at 65°C for 5 minutes, and then mixed with the DNA fragments. The mixture was treated with T₄ phage DNA ligase at 10°C for 24 hours and then heated at 65°C for 5 minutes. Two times volume of ethanol was added to the mixture. Plasmids carrying the chromosomal DNA fragments were precipitated and collected. (3) Transformation of the microorganism with plasmids having gene for extracellular production of penicillinase. Escherichia coli HB101 which is a hybrid strain of Escherichia coli K-12 and Escherichia coli B, was inoculated in 10ml of LB-broth [containing 10g of tryptone (Difco Laboratories, Detroit, Mich.), 5g of yeast extract, 1g of glucose and 10g of NaCl in one liter of deionized water; pH was adjusted to 7.0] and cultured at 37°C with shaking until the latter logarithmic phase. The cells were collected and suspended in an ice-cold CaCl₂ solution of 0.03M (final concentration) to obtain competent cells. The cell suspension and the plasmid solution obtained in step (2) were combined and kept on ice for 60 minutes: The mixture was heated to 42°C for 1 to 2 minutes to introduce the plasmid DNA into the cells. This cell suspension was inoculated in fresh LB-broth and cultured at 37°C for 3 to 5 hours with shaking. The cells were collected and washed to obtain Escherichia coli HB101 (pEAP2) having the capability of penicillinase production. Example 2 Perparation and purification of plasmid pEAP2 1. Culture growth of bacterial cells using Escherichia coli HB101 (pEAP2) [FERM BP-468] Example 3 Escherichia coli HB101 (pEAP2) (FERM BP-468) obtained in step (3) of Example 1 was inoculated in 500ml-flasks containing 100ml of LB-broth (containing 10g of tryptone, 5g of yeast extract, lg of glucose, 2g of glycerol, and 10g of NaCl in one liter of water) and cultured at 37°C with shaking. Cell growth (cell amount) was measured by optical density at 660nm. Extracellular and intracellular penicillinase activities were assayed by the modified Sargent's method [Sawai et al; Antimicrob. Agents Chemother. 13, 910 (1978)], wherein the enzyme quantity hydrolysing at 30°C one micromole of benzylpenicillin per one minute constitutes one unit of penicillinase. As shown in Fig. 1, cell growth of the transformant reached the maximum after 16 hours cultivation and extracellular penicillinase activity began to increase after 20 hours and reached the maximum (about 20 units/ml) after 28 hours cultivation. Extracellular penicillinase produced was very stable and, as shown in Fig. 1 a, the production was kept high even after 48 hours cultivation and reached more than 80% of total enzyme production. In contrast, intracellular penicillinase production was detected at an early phase (after 8 to 20 hours cultivation). But, the maximum was only 8 units/ml or about 10% of total enzyme production and furthermore, the intracellular production decreased quickly. No intracellular penicillinase activity was observed after 48 hours cultivation. Fig. 1 b shows percentages of extracellular and intracellular penicillinase activities on total enzyme activity. As a comparison, Bacillus sp. No. 170 (FERN BP-467) which is a DNA donor and Escherichia coli HB101 (pBR322) (carrying plasmid pBR322 having genetic information of penicillinase production) [Boyer et al; Gene, vol. 2, p.95-113 (1977)] were cultured and penicillinase activities were assayed. Bacillus sp. No. 170 was inoculated in 500ml-flasks containing 100ml of the broth (containing 2.0g of glucose or glycerol, 5.0g of yeast extract, 5.0g of polypeptone, 1.0g of K₂HPO₄ , 0.2g of MgSO₄·7H₂O and 10g of NaHCO₃ in one liter of water and adjusted to pH 9.0) and cultured at 37°C with shaking. Extracellular penicillinase activity in the culture fluid was observed every four hours. It reached the maximum (19 units/ml) after 12 hours cultivation and then quickly decreased. No extracellular penicillinase activity was observed after 40 hours cultivation (Fig. 2). On the other hand, Escherichia coli HB101 (pBR322) was inoculated in 500ml-flasks containing 100ml of LB-broth which is the same as that used in the cultivation of Escherichia coli HB101 (pEAP2) and cultured at 37°C with shaking. As shown in Fig 3 a, intracellular penicillinase activity reached the maximum (35 units/ml) after 20 hours cultivation and it was more than 80% of total enzyme activity. But it decreased quickly. Extracellular penicillinase activity was less than 10% of total enzyme activity. Fig. 3 b shows percentages of extracellular and intracellular penicillinase activities on total enzyme activity. Identification of Penicillinase: The culture fluid of the transformant obtained in step (3) of Example 1 was centrifuged at 10,000 x g for 10 minutes. The supernatant fluid was brought to 80% saturation with ammonium sulfate. The precipitate was dissolved in water and the solution was dialyzed overnight against 0.05M phosphate buffer containing 0.1M NaCl (pH 7.0). The dialysate was applied on a Sephadex G-75 column equilibrated with the phosphate buffer to obtain purified penicillinase. Similarly, the culture fluid of Bacillus sp. No. 170 was treated to obtain purified penicillinase. For the identification of Escherichia coli HB101 (pEAP2) penicillinase with Bacillus sp. No. 170 penicillinase, effects of pH on activity, thermal stability and molecular weight of each penicillinase were investigated. As a result, the enzymes were identical with each other as shown below. (a) Stability of the enzyme was investigated in buffer solutions of various pH values. The mixture was incubated at 30°C for 45 minutes. Both the enzymes were stable between pH 7 and pH 9 and the optimum pH values for enzyme action were 6.0 to 7.0. (b) Thermal stability was investigated as follows. The enzymes were dissolved in 0.05M phosphate buffer of pH 7.0 and the solutions were heated at the selected temperature for 10 minutes. The residual activities were measured at pH 7.0. Both the enzymes were stable up to 50°C. (c) Estimation of molecular weight of the enzymes was done by using the Sephadex gel filtration method. Estimated molecular weight of both the enzymes was 27,000 to 22,000. Example 4 Culture conditions for penicillinase production by Escherichia coli HB101 (pEAP2) (FERN BP-468) were examined in the various media. The other culture conditions were the same as those in Example 3. Effects of components of LB-broth on penicillinase production are given in Table 2. The concentration of tryptone, tryptose, polypeptone and NaCl was 1% by weight. Effects of carbon sources of LB-broth on penicillinase production are given in Table 3. The concentration of glucose, starch, sucrose and maltose was 0.1%, that of glycerol was 0.2% and that of NaCl was 1%. Effects of NaCl on penicillinase production were examined using the media containing 1% of tryptone, 0.1% of glucose, 0.2% of glycerol, 1% of yeast extract and the indicated amount of NaCl . Results are given in Table 4. Example 5 Escherichia coli HB101, Escherichia coli HB101 (pMB9) and Escherichia coli HB101 (pEAP2) (FERN BP-468) were cultured in the same LB-broth as used in Example 3 at 37°C for 20 hours with shaking. Enzyme activities of alkaline phosphatase and β-galactosidase were measured by optical density at 420nm. Results are given in Table 5.

Claims: A recombinant plasmid which is capable of inducing the extracellular secretion of penicillinase in Escherichia coli transformed with said plasmid, said plasmid comprising: (a) a restriction fragment of the chromosomal DNA of Bacillus 5p. No. 170 (FERM BP-467) prepared with a first restriction enzyme, preferably a HindIII fragment having a length of about 4kb, which codes for the extracellular secretion of penicillinase; and (b) a vector plasmid DNA fragment, preferably a DNA fragment of pMB9, prepared with a second restriction enzyme which does not interfere with the genetic information carried on the restriction fragment of (a). The recombinant plasmid according to claim 1, wherein the vector plasmid is plasmid pMB9. The recombinant plasmid according to claim 1, which is the plasmid pEAP2 (FERM BP-468). A host organism of the genus Escherichia, preferably of the species Escherichia coli, which is transformed with a recombinant plasmid according to any one of Claims 1 to 3. A host organism according to Claim 4, which is the strain Escherichia coli HB101 and which is capable of extracellular secretion of penicillinase. A method for the construction of a recombinant plasmid according to Claim 1, which comprises the steps of: (a) preparing with a first restriction enzyme a chromosomal DNA fragment of Bacillus sp. No. 170 (FEB BP-467) which codes for the extracellular secretion of penicillinase; (b) digesting a vector plasmid DNA with a second restriction enzyme which does not interfere with the genetic information carried on the chromosomal DNA fragment; (c) treating said chromosomal DNA fragment and said digested vector plasmid DNA with DNA ligase to form the recombinant plasmid DNA; and (d) isolating the recombinant plasmid DNA from a transformed host cell which exhibits a Penicillinase-producing phenotype. The method according to Claim 6, wherein the first and second restriction enzyme is the restriction enzyme Hind III. The method according to Claim 6, wherein the hector plasmid is pMB9. The method according to claim 6, wherein the recombinant plasmid is plasmid pEAP2 (FERM BP-468). A method for the extracellular production of penicillinase in which a transformant according to Claim 4 or 5 is cultivated and which comprises: (a) inocculating a medium containing an inorganic salt which is a sodium salt or a potassium salt with the transformant; (b) keeping on culturing the transformant after the concentration of the cells reached the maximum and until the production and accumulation of penicillinase in the medium reached the maximum. The method of Claim 10, wherein the inorganic salt is sodium chloride or potassium chloride. The method of Claim 10 or 11, wherein the inorganic salt is used in an amount of 0.5 to 3.0 % by weight of the medium. The method of any one of Claims 10 to 12, wherein the transformant is cultured for 12 to 48 hours.

Inventors: HONDA, HIROSHI, HORIKOSHI, KOKI, KATO, CHIAKI, KUDO, TOSHIAKI
Applicants: RIKAGAKU KENKYUSHO
Application year: 1984
Main classification: C12N15
IPC codes: C12N9, C12N15, C12N1